Our Impact
Cure SMA Reaches Thousands of Families in 2015
Each year, Cure SMA provides thousands of families with vital support and resources to help them live active, engaged and hopeful lives. Our programs provide […]
Read More ›Great Progress, Greater Need
In the last few years, we’ve gotten closer to an approved treatment than we ever have been. Through research funded by Cure SMA, we’ve identified […]
Read More ›Cure SMA and Other Venture Philanthropy Leaders Share Insight at Partnering for Cures Panel
Cure SMA President Kenneth Hobby was a featured panelist at Partnering for Cures, a conference convened by the Milken Institute’s FasterCures initiative. At the event, […]
Read More ›Cure SMA-Funded Researchers Publish Paper in Journal Pediatrics
Cure SMA-funded researchers Rebecca Hurst Davis and Kathy Swoboda have published a paper, “Responses to Fasting and Glucose Loading in a Cohort of Well Children […]
Read More ›Cure SMA Announces Nearly $2 Million in New Planned Research Funding
Cure SMA has announced plans to fund $1.995 million in new research grants over the next several months. This includes funding for all four areas […]
Read More ›SMA Drug Pipeline Grows to 18 Programs
We’ve recently released an update to our SMA drug pipeline. This latest version shows the continued growth of the pipeline, setting several new marks for […]
Read More ›Collaborative Ways Cure SMA is Driving Research Results
Much as families in our community often work together to start a chapter, organize an event, or raise awareness of SMA, researchers must work together […]
Read More ›Update on SMA-FDA Interactions
The SMA drug pipeline has grown dramatically in just over a decade. Of the 17 programs in the pipeline, seven of these are in clinical […]
Read More ›Cure SMA Funds $1.85 Million in New Research Grants in 2014-2015
Over the past few months, Cure SMA has announced a total of $1.85 million in new research funding. Our model is designed to fund both […]
Read More ›Cure SMA Announces Additional $445,000 for Nationwide Children’s Hospital Gene Therapy Program led by Brian Kaspar, PhD
Cure SMA, the leading organization dedicated to the treatment and cure of spinal muscular atrophy (SMA), recently provided an additional $445,000 grant toward a gene […]
Read More ›